Jan 08, 2024 / 11:45PM GMT
Christopher Thomas Schott - JPMorgan Chase & Co, Research Division - Senior Analyst
Good afternoon, everybody. I'm Chris Schott at JPMorgan, and it's my pleasure to be introducing Zoetis today. From the company, we'll have a presentation from Kristin Peck, CEO, and then we'll go to a Q&A session after that. Obviously, a lot of exciting things going on at Zoetis, including the recent Librela launch, and we'll hear more about that. But let me turn this over to Kristin, and thanks for joining us.
Kristin C. Peck - Zoetis Inc. - CEO & Director
Hello, everyone. It is great to be back. Thank you, Chris, for the introduction, to share a little bit about Zoetis. But I don't think it would be a presentation at the JPMorgan conference if you didn't have the legal disclaimer of forward-looking statements and non-GAAP financials, which you can find the more information on these risks and the reconciliations in the deck we posted on our website as well as in all of our SEC filings. So with that said, let's get started.
Let me share a little bit about
Zoetis Inc at JPMorgan Healthcare Conference Transcript
Jan 23, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers